Search Results 2761-2770 of 19206 for prostate cancer

  1. A Study to Evaluate Hepcidin Mimetic in Patients With Polycythemia Vera - Mayo Clinic

    History of invasive malignancies within the last 5 years, except localized cured prostate cancer, cervical cancer, and ductal carcinoma in situ (DCIS).

  2. Phenylalanine in diet soda: Is it harmful? - Mayo Clinic

    Does soy really affect breast cancer risk? Don't get tricked by these 3 heart-health myths · High-protein diets · How to track saturated fat · Is there a ...

  3. Hematology - Clinical trials

    ... tumor malignancies or lymphoma. A Study of Proton Radiation Divided into Fewer Doses for Low Risk Prostate Cancer. Rochester, Minn., Scottsdale/Phoenix, Ariz ...

  4. Health Topics - Mayo Clinic News Network

    Cancer. Mayo Clinic Minute: What is TIL therapy? Alex Osiadacz. September 17 ... Mayo Clinic Minute: What you should know about prostate cancer screening.

  5. Gallbladder polyps: Can they be cancerous? - Mayo Clinic

    Are gallbladder polyps associated with gallbladder cancer? Answer From Sahil Khanna, M.B.B.S., M.S.. Gallbladder polyps are growths that stick out from the ...

  6. Publications - Patricio C. Gargollo, M.D. - Mayo Clinic

    ... cancer. J Assist Reprod Genet. 2021 Feb; 38 (2):495-501 Epub 2021 Jan 03 ... Management of complications of prostate cancer treatment. CA Cancer J Clin ...

  7. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... tumor, Retroperitoneal sarcoma, Liver tumor, Stage 4 colorectal cancer. Show ... Orchestrating Care (and robotic surgery) for Prostate Cancer - Mayo Clinic ...

  8. Mayo Clinic Expert Says Heart Risks From Unnecessarily Treating "Low T" Serious Concern

    High testosterone levels can also promote the growth of the prostate gland." TRT :15. Dr. Young says patients suspected of having low male hormone levels may ...

  9. Health Topics - Mayo Clinic News Network

    Cancer. Mayo Clinic Minute: What is TIL therapy? Alex Osiadacz. September 17 ... Mayo Clinic Minute: What you should know about prostate cancer screening.

  10. Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF - Mayo Clinic

    History of malignancy within 5 years (except non-high-grade skin cancers, carcinoma-in-situ, or low-grade prostate cancer). Weight change (gain or loss) of ...